Your browser doesn't support javascript.
loading
Brain-derived neurotrophic factor (BDNF) plasma concentration in patients diagnosed with premature ovarian insufficiency (POI).
Czyzyk, Adam; Filipowicz, Dorota; Podfigurna, Agnieszka; Ptas, Paula; Piestrzynska, Malgorzata; Smolarczyk, Roman; Genazzani, Andrea R; Meczekalski, Blazej.
Affiliation
  • Czyzyk A; a Department of Gynecological Endocrinology , Poznan University of Medical Sciences , Poznan , Poland.
  • Filipowicz D; b Students Scientific Association of the Department of Gynecological Endocrinology, Poznan University of Medical Sciences , Poznan , Poland.
  • Podfigurna A; a Department of Gynecological Endocrinology , Poznan University of Medical Sciences , Poznan , Poland.
  • Ptas P; b Students Scientific Association of the Department of Gynecological Endocrinology, Poznan University of Medical Sciences , Poznan , Poland.
  • Piestrzynska M; b Students Scientific Association of the Department of Gynecological Endocrinology, Poznan University of Medical Sciences , Poznan , Poland.
  • Smolarczyk R; c Department of Gynecological Endocrinology , Warsaw Medical University , Warsaw , Poland , and.
  • Genazzani AR; d Department of Reproductive Medicine and Child Development , Division of Gynecology and Obstetrics, University of Pisa , Pisa , Italy.
  • Meczekalski B; a Department of Gynecological Endocrinology , Poznan University of Medical Sciences , Poznan , Poland.
Gynecol Endocrinol ; 33(5): 413-417, 2017 May.
Article de En | MEDLINE | ID: mdl-28277119
ABSTRACT
Premature ovarian insufficiency (POI) is defined as a cessation of function of ovaries in women younger than 40 years old. Brain-derived neurotrophic factor (BDNF) is a protein critically involved in neuronal growth and metabolism. BDNF also has been shown to be important regulator of oocyte maturation. Recent data show that BDNF can be potentially involved in POI pathology. The aim of the study was to assess the BDNF plasma concentrations in patients diagnosed with idiopathic POI. 23 women diagnosed with POI (age 31 ± 7 years) and 18 (age 31 ± 3) controls were included to the study, matched according to age and body mass index. The BDNF concentrations were measured using competitive enzyme-linked immunosorbent assay (ELISA). Hormonal and metabolic parameters were measured in all individuals, in controls in late follicular phase. The POI group demonstrated lower mean plasma concentrations of BDNF (429.25 ± 65.52 pg/ml) in comparison to healthy controls (479.75 ± 34.75 pg/ml, p = 0.0345). The BDNF plasma concentration correlated negatively (R = -0.79, p < 0.001) with number of months since last menstrual period. There was a positive correlation between BDNF and progesterone in controls. In conclusion, POI patients show significantly lower BDNF plasma concentration and it correlates with the duration of amenorrhea. This observation brings important potential insights to the pathology of POI.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ménopause précoce / Insuffisance ovarienne primitive / Facteur neurotrophique dérivé du cerveau Type d'étude: Diagnostic_studies / Observational_studies / Risk_factors_studies Limites: Adult / Female / Humans Langue: En Journal: Gynecol Endocrinol Sujet du journal: ENDOCRINOLOGIA / GINECOLOGIA Année: 2017 Type de document: Article Pays d'affiliation: Pologne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Ménopause précoce / Insuffisance ovarienne primitive / Facteur neurotrophique dérivé du cerveau Type d'étude: Diagnostic_studies / Observational_studies / Risk_factors_studies Limites: Adult / Female / Humans Langue: En Journal: Gynecol Endocrinol Sujet du journal: ENDOCRINOLOGIA / GINECOLOGIA Année: 2017 Type de document: Article Pays d'affiliation: Pologne
...